These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31965712)

  • 1. Prognostic Factors in Pediatric Early Liver Retransplantation.
    Cañon Reyes I; Halac E; Aredes D; Lauferman L; Cervio G; Dip M; Minetto J; Reijenstein H; Meza V; Gole M; Jacobo Dillon A; Imventarza O
    Liver Transpl; 2020 Apr; 26(4):528-536. PubMed ID: 31965712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waiting list outcome of Peld/Meld exceptions: A single-center experience in Argentina.
    Lauferman L; Dip M; Halac E; Cervio G; Aredes D; Capparelli M; Reijenstein H; Minetto J; Rojas L; Goñi J; Jacobo Dillon A; Martinitto R; Imventarza O
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results after the adoption of a MELD/PELD-based liver allocation policy in Argentina.
    Dip M; Cejas N; Cervio G; Villamil F; Tagliafichi V; Hansen Krogh D; Imventarza O; Soratti C; Bisigniano L
    Pediatr Transplant; 2015 Feb; 19(1):56-61. PubMed ID: 25414131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
    Maduka RC; Abt PL; Goldberg DS
    Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of causes and outcomes in pediatric liver retransplantation].
    Sun C; Dong C; Meng XC; Wang K; Qin H; Han C; Yang Y; Zhang FB; Zheng WP; Song ZL; Li HH; Gao W; Shen ZY
    Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):353-358. PubMed ID: 33915625
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.
    Martel-Laferrière V; Michel A; Schaefer S; Bindal S; Bichoupan K; Branch AD; Huprikar S; Schiano TD; Perumalswami PV
    Transpl Infect Dis; 2015 Aug; 17(4):527-35. PubMed ID: 25929731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.
    Chang CH; Bryce CL; Shneider BL; Yabes JG; Ren Y; Zenarosa GL; Tomko H; Donnell DM; Squires RH; Roberts MS
    JAMA Pediatr; 2018 Nov; 172(11):1070-1077. PubMed ID: 30242345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    Saldaña RS; Schrem H; Barthold M; Kaltenborn A
    PLoS One; 2017; 12(1):e0170499. PubMed ID: 28129338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Liver Transplant Waiting List in Our Center.
    Emek E; Yesim Kara Z; Demircan FH; Serin A; Yazici P; Sahin T; Tokat Y; Bozkurt B
    Transplant Proc; 2019 Sep; 51(7):2413-2415. PubMed ID: 31474297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes.
    Freire MP; Soares Oshiro IC; Bonazzi PR; Guimarães T; Ramos Figueira ER; Bacchella T; Costa SF; Carneiro D'Albuquerque LA; Abdala E
    Liver Transpl; 2013 Sep; 19(9):1011-9. PubMed ID: 23744748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult Liver Disease Prognostic Modelling for Long-term Outcomes in Biliary Atresia: An Observational Cohort Study.
    Jain V; Burford C; Alexander EC; Dhawan A; Joshi D; Davenport M; Heaton N; Hadzic N; Samyn M
    J Pediatr Gastroenterol Nutr; 2021 Jul; 73(1):93-98. PubMed ID: 33720092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.